drugset / Trial / NCT05960097
A Study on the Safety and Immune Response of Investigational COVID-19 mRNA Vaccines in Healthy Adults
RandomizedParallel-groupTriple-blindPrevention
Summary
The purpose of Part A of this study is to assess the immune response and safety of a booster dose of investigational COVID-19 mRNA vaccines in healthy adults. The study will compare the investigational vaccines to control vaccine. The purpose of Part B of this study is to assess the immune response and safety of a booster dose of investigational COVID-19 mRNA vaccines in healthy adults. The study will compare the investigational vaccine under three different storage conditions.
Timeline
- Start
- 2023-08-01
- Primary completion
- 2024-08-30
- Completion
- 2024-08-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | CV0601 | Unknown | — | Intramuscular |
| Subject | CV0701 | Unknown | — | Intramuscular |
| Subject | CV0801 | Unknown | — | Intramuscular |